Fosun Pharmaceutical bought Concert Pharmaceuticals Shanghai Fosun Pharmaceutical from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Shanghai Fosun Pharmaceutical

2196

HK$13.72

0.00%

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Alrosa approved dividends

10/1/24 ALRS

MD Medical has opened a new clinic

10/1/24 MDMG

Arenadata's IPO went over the top

10/1/24 DATA

Shareholders of Seligdar approved dividends

10/1/24 SELG

Yury Denisov resigns as Chairman of the Management Board of MosBirch

9/30/24 MOEX

Shareholders of NovaBev Group approved dividends

9/30/24 BELU

X5 Group opened its 2,000th Chizhik store

9/30/24 FIVE

Globaltrans shareholder meeting postponed to October 7

9/30/24 GLTR

NLMK's sales in 1H decreased by 11%

9/30/24 NLMK

Rusagro increases stake in Agro-Belogorie to 47.5%

9/30/24 AGRO